Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Effects of APOE on brain white matter microstructure in healthy adults.

Westlye LT, Reinvang I, Rootwelt H, Espeseth T.

Neurology. 2012 Nov 6;79(19):1961-9. doi: 10.1212/WNL.0b013e3182735c9c. Epub 2012 Oct 24.

PMID:
23100402
2.

Apolipoprotein E gene and early age-related maculopathy: the Atherosclerosis Risk in Communities Study.

Wong TY, Shankar A, Klein R, Bray MS, Couper DJ, Klein BE, Sharrett AR, Folsom AR.

Ophthalmology. 2006 Feb;113(2):255-9. Epub 2006 Jan 10.

PMID:
16406547
3.

White matter alterations in cognitively normal apoE ε2 carriers: insight into Alzheimer resistance?

Chiang GC, Zhan W, Schuff N, Weiner MW.

AJNR Am J Neuroradiol. 2012 Aug;33(7):1392-7. doi: 10.3174/ajnr.A2984. Epub 2012 Mar 1.

4.

APOE Polymorphism Affects Brain Default Mode Network in Healthy Young Adults: A STROBE Article.

Su YY, Liang X, Schoepf UJ, Varga-Szemes A, West HC, Qi R, Kong X, Chen HJ, Lu GM, Zhang LJ.

Medicine (Baltimore). 2015 Dec;94(52):e1734. doi: 10.1097/MD.0000000000001734.

5.

The APOE ɛ4 allele modulates brain white matter integrity in healthy adults.

Heise V, Filippini N, Ebmeier KP, Mackay CE.

Mol Psychiatry. 2011 Sep;16(9):908-16. doi: 10.1038/mp.2010.90. Epub 2010 Sep 7.

PMID:
20820167
6.

APOE genotype and serum cholesterol in predicting risk for early death from ischemic stroke in men and women.

Gromadzka G, Barańska-Gieruszczak M, Ciesielska A, Sarzyńska-Dlugosz I, Członkowska A.

Cerebrovasc Dis. 2005;20(5):291-8. Epub 2005 Aug 30.

PMID:
16131797
7.

Apolipoprotein E epsilon4 allele and familial aggregation of Alzheimer disease.

Martinez M, Campion D, Brice A, Hannequin D, Dubois B, Didierjean O, Michon A, Thomas-Anterion C, Puel M, Frebourg T, Agid Y, Clerget-Darpoux F.

Arch Neurol. 1998 Jun;55(6):810-6.

PMID:
9626772
8.

Association of APOE epsilon2/epsilon3/epsilon4 and promoter gene variants with dementia but not cardiovascular mortality in old age.

Heijmans BT, Slagboom PE, Gussekloo J, Droog S, Lagaay AM, Kluft C, Knook DL, Westendorp RG.

Am J Med Genet. 2002 Jan 22;107(3):201-8.

PMID:
11807900
9.

ApoE genotype in relation to AD and cholesterol: a study of 2,326 Chinese adults.

Liu HC, Hong CJ, Wang SJ, Fuh JL, Wang PN, Shyu HY, Teng EL.

Neurology. 1999 Sep 22;53(5):962-6.

PMID:
10496253
10.

Altered brain white matter integrity in healthy carriers of the APOE epsilon4 allele: a risk for AD?

Persson J, Lind J, Larsson A, Ingvar M, Cruts M, Van Broeckhoven C, Adolfsson R, Nilsson LG, Nyberg L.

Neurology. 2006 Apr 11;66(7):1029-33.

PMID:
16606914
11.

The APOE epsilon4 allele is associated with decline on delayed recall performance in community-dwelling older adults.

O'Hara R, Yesavage JA, Kraemer HC, Mauricio M, Friedman LF, Murphy GM Jr.

J Am Geriatr Soc. 1998 Dec;46(12):1493-8.

PMID:
9848808
12.

Accelerated decline in apolipoprotein E-epsilon4 homozygotes with Alzheimer's disease.

Craft S, Teri L, Edland SD, Kukull WA, Schellenberg G, McCormick WC, Bowen JD, Larson EB.

Neurology. 1998 Jul;51(1):149-53.

PMID:
9674794
13.

Apolipoprotein E genotype related differences in brain lesions of multiple sclerosis.

Fazekas F, Strasser-Fuchs S, Schmidt H, Enzinger C, Ropele S, Lechner A, Flooh E, Schmidt R, Hartung HP.

J Neurol Neurosurg Psychiatry. 2000 Jul;69(1):25-8.

14.

Increased CSF cortisol in AD is a function of APOE genotype.

Peskind ER, Wilkinson CW, Petrie EC, Schellenberg GD, Raskind MA.

Neurology. 2001 Apr 24;56(8):1094-8.

PMID:
11320185
15.

The epsilon2 and epsilon4 alleles of the apolipoprotein gene are associated with age-related macular degeneration.

Baird PN, Guida E, Chu DT, Vu HT, Guymer RH.

Invest Ophthalmol Vis Sci. 2004 May;45(5):1311-5.

PMID:
15111582
16.

The effects of APOE on brain activity do not simply reflect the risk of Alzheimer's disease.

Trachtenberg AJ, Filippini N, Cheeseman J, Duff EP, Neville MJ, Ebmeier KP, Karpe F, Mackay CE.

Neurobiol Aging. 2012 Mar;33(3):618.e1-618.e13. doi: 10.1016/j.neurobiolaging.2010.11.011. Epub 2011 Jan 12.

PMID:
21232817
17.

A case-control study on the effects of the apolipoprotein E genotypes in nonalcoholic fatty liver disease.

De Feo E, Cefalo C, Arzani D, Amore R, Landolfi R, Grieco A, Ricciardi W, Miele L, Boccia S.

Mol Biol Rep. 2012 Jul;39(7):7381-8. doi: 10.1007/s11033-012-1570-7. Epub 2012 Feb 15.

PMID:
22350157
18.

Impact of apolipoprotein E (ApoE) polymorphism on brain ApoE levels.

Riddell DR, Zhou H, Atchison K, Warwick HK, Atkinson PJ, Jefferson J, Xu L, Aschmies S, Kirksey Y, Hu Y, Wagner E, Parratt A, Xu J, Li Z, Zaleska MM, Jacobsen JS, Pangalos MN, Reinhart PH.

J Neurosci. 2008 Nov 5;28(45):11445-53. doi: 10.1523/JNEUROSCI.1972-08.2008.

19.

Regional brain atrophy in cognitively intact adults with a single APOE epsilon4 allele.

Wishart HA, Saykin AJ, McAllister TW, Rabin LA, McDonald BC, Flashman LA, Roth RM, Mamourian AC, Tsongalis GJ, Rhodes CH.

Neurology. 2006 Oct 10;67(7):1221-4.

PMID:
17030756
20.

Association between apolipoprotein E genotype and Alzheimer disease in African American subjects.

Graff-Radford NR, Green RC, Go RC, Hutton ML, Edeki T, Bachman D, Adamson JL, Griffith P, Willis FB, Williams M, Hipps Y, Haines JL, Cupples LA, Farrer LA.

Arch Neurol. 2002 Apr;59(4):594-600.

PMID:
11939894

Supplemental Content

Support Center